Corrigendum to 'What type 1 diabetes endotype is most suitable for anti-CD3 antibodies prevention trials?' [JDC, Vol. 39, Issue 10, October 2025, 109132].
Saved in:
| Title: | Corrigendum to 'What type 1 diabetes endotype is most suitable for anti-CD3 antibodies prevention trials?' [JDC, Vol. 39, Issue 10, October 2025, 109132]. |
|---|---|
| Authors: | Roma-Wilson, Maria Aurora1 (AUTHOR), Pozzilli, Paolo1,2,3 (AUTHOR) p.pozzilli@unicampus.it |
| Source: | Journal of Diabetes & its Complications. Mar2026, Vol. 40 Issue 3, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 10568727 |
|---|---|
| DOI: | 10.1016/j.jdiacomp.2025.109230 |
